Technical Analysis for TTNP - Titan Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 1.86 -1.06% -0.02
TTNP closed down 1.06 percent on Friday, March 22, 2019, on 17 percent of normal volume.

Earnings due: Apr 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical TTNP trend table...

Date Alert Name Type % Chg
Mar 22 20 DMA Support Bullish 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 21 Bollinger Band Squeeze Range Contraction -1.06%
Mar 21 Inside Day Range Contraction -1.06%
Mar 20 New 52 Week Closing High Bullish -7.00%
Mar 20 Pocket Pivot Bullish Swing Setup -7.00%
Mar 20 Bollinger Band Squeeze Range Contraction -7.00%
Mar 19 Bollinger Band Squeeze Range Contraction 3.91%
Mar 19 Narrow Range Bar Range Contraction 3.91%
Mar 19 BB Squeeze Started Range Contraction 3.91%

Older signals for TTNP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. Its Probuphine is designed to maintain a stable, around the clock blood level of the medicine buprenorphine in patients for six months following a single treatment; and utilizes ProNeura, a novel, proprietary, and long-term drug delivery technology. The company's ProNeura is also used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. It is also developing Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. The company was founded in 1992 and is based in South San Francisco, California.
Pharmaceutical Chemical Compounds Organic Compounds Schizophrenia Parkinson's Disease Morphinans Opioids Buprenorphine Drug Rehabilitation Atypical Antipsychotics Chronic Conditions Fanapt Iloperidone
Is TTNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.45
52 Week Low 0.172
Average Volume 1,821,973
200-Day Moving Average 0.7834
50-Day Moving Average 1.3828
20-Day Moving Average 1.8155
10-Day Moving Average 1.818
Average True Range 0.1469
ADX 52.14
+DI 35.8812
-DI 10.0779
Chandelier Exit (Long, 3 ATRs ) 2.0093
Chandelier Exit (Short, 3 ATRs ) 1.8107
Upper Bollinger Band 1.9524
Lower Bollinger Band 1.6786
Percent B (%b) 0.66
BandWidth 15.081245
MACD Line 0.1206
MACD Signal Line 0.1413
MACD Histogram -0.0207
Fundamentals Value
Market Cap 39.44 Million
Num Shares 21.2 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -3.05
Price-to-Sales 259.08
Price-to-Book 6.11
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.00
Resistance 3 (R3) 1.99 1.94 1.97
Resistance 2 (R2) 1.94 1.91 1.94 1.96
Resistance 1 (R1) 1.90 1.88 1.88 1.91 1.96
Pivot Point 1.85 1.85 1.84 1.85 1.85
Support 1 (S1) 1.81 1.82 1.79 1.82 1.76
Support 2 (S2) 1.76 1.79 1.76 1.76
Support 3 (S3) 1.72 1.76 1.75
Support 4 (S4) 1.73